FDA waives trial requirement for Stelera biosimilar, easing the copycat’s path
First-of-its-kind case continues EMA and MHRA harmonisation, streamlining the global…
First-of-its-kind case continues EMA and MHRA harmonisation, streamlining the global biosimilar approval pathway.